Publications | Lund University Publications

1 – 9 of 9

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=issn+exact+%222051-1426%22&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2025
Mark First-in-human, multicenter, open-label, phase I study of ATOR-1017 (evunzekibart), a 4-1BB antibody, in patients with advanced solid malignancies
Carneiro, Ana ^LU ; Hahn, Amanda ; Ellmark, Peter ^LU ; Enell Smith, Karin ^LU ; Schultz, Lena ; Ambarkhane, Sumeet ; Yachnin, Jeffrey and Ullenhag, Gustav J (2025) In Journal for ImmunoTherapy of Cancer 13.
- Contribution to journal › Article
2024
Mark Blocking IL1RAP on cancer-associated fibroblasts in pancreatic ductal adenocarcinoma suppresses IL-1-induced neutrophil recruitment
Hansen, Nils ^LU ; Peña-Martínez, Pablo ^LU ; Skoog, Petter ; Reinbach, Katrin ^LU ; Hansen, Finja C. ^LU ; Faria, Susanne Larsson ; Grönberg, Caitríona ; Abdilleh, Kawther ; Magnusson, Susanne and Von Wachenfeldt, Karin , et al. (2024) In Journal for ImmunoTherapy of Cancer 12(12).
- Contribution to journal › Article
2023
Mark Intratumoral T-cell and B-cell receptor architecture associates with distinct immune tumor microenvironment features and clinical outcomes of anti-PD-1/L1 immunotherapy
Schina, Aimilia ; Sztupinszki, Zsofia ; Marie Svane, Inge ; Szallasi, Zoltan ; Jönsson, Göran ^LU and Donia, Marco (2023) In Journal for ImmunoTherapy of Cancer 11(8).
- Contribution to journal › Article
Mark Combining histological grade, TILs, and the PD-1/PD-L1 pathway to identify immunogenic tumors and de-escalate radiotherapy in early breast cancer : A secondary analysis of a randomized clinical trial
Stenmark Tullberg, Axel ; Sjöström, Martin ^LU ; Tran, Lena ^LU ; Niméus, Emma ^LU ; Killander, Fredrika ^LU ; Kovács, Anikó ; Lundstedt, Dan ; Holmberg, Erik and Karlsson, Per (2023) In Journal for ImmunoTherapy of Cancer 11(5).
- Contribution to journal › Article
2022
Mark Bispecific antibodies targeting CD40 and tumor-associated antigens promote cross-priming of T cells resulting in an antitumor response superior to monospecific antibodies
Hägerbrand, Karin ^LU ; Varas, Laura ^LU ; Deronic, Adnan ^LU ; Nyesiga, Barnabas ; Sundstedt, Anette ^LU ; Ljung, Lill ; Sakellariou, Christina ^LU ; Werchau, Doreen ; Thagesson, Mia and Gomez Jimenez, David ^LU , et al. (2022) In Journal for ImmunoTherapy of Cancer 10(11).
- Contribution to journal › Article
2021
Mark Clinical efficacy of T-cell therapy after short-term BRAF-inhibitor priming in patients with checkpoint inhibitor-resistant metastatic melanoma
Borch, Troels Holz ; Harbst, Katja ^LU ; Rana, Aynal Haque ; Andersen, Rikke ; Martinenaite, Evelina ; Kongsted, Per ; Pedersen, Magnus ; Nielsen, Morten ; Kjeldsen, Julie Westerlin and Kverneland, Anders Handrup , et al. (2021) In Journal for ImmunoTherapy of Cancer 9(7).
- Contribution to journal › Article
2020
Mark Transcriptomic profiling of T-cell populations in non-muscle invasive and muscle invasive bladder cancer.
Sincic, Viktor ^LU ; Abolhalaj, Milad ^LU ; Lilljebjörn, Henrik ^LU ; Aab, Alar ^LU ; Hägerbrand, Karin ^LU ; Ellmark, Peter ^LU ; Fioretos, Thoas ^LU ; Borrebaeck, Carl ^LU ; Liedberg, Fredrik ^LU and Lundberg, Kristina ^LU (2020) The Society for Immunotherapy of Cancer's (SITC) 35th annual meeting In Journal for ImmunoTherapy of Cancer 8(Suppl. 3).
- Contribution to journal › Published meeting abstract
2019
Mark The CTLA-4 x OX40 bispecific antibody ATOR-1015 induces anti-tumor effects through tumor-directed immune activation
Kvarnhammar, Anne Månsson ; Veitonmäki, Niina ; Hägerbrand, Karin ^LU ; Dahlman, Anna ^LU ; Smith, Karin Enell ^LU ; Fritzell, Sara ^LU ; Von Schantz, Laura ^LU ; Thagesson, Mia ; Werchau, Doreen and Smedenfors, Kristine , et al. (2019) In Journal for ImmunoTherapy of Cancer 7(1).
- Contribution to journal › Article
2015
Mark Tasquinimod triggers an early change in the polarization of tumor associated macrophages in the tumor microenvironment.
Olsson, Anders ; Nakhlé, Jessica ; Sundstedt, Anette ; Plas, Pascale ; Bauchet, Anne-Laure ; Pierron, Valérie ; Bruetschy, Luce ; Deronic, Adnan ^LU ; Törngren, Marie and Liberg, David , et al. (2015) In Journal for ImmunoTherapy of Cancer 3.
- Contribution to journal › Article

your query:: Remove issn: 2051-1426